Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 6, 2011VirusesOpen Access

Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

ATAnna Le TortorecInsermSWSuzanne WilleyMonash UniversitySNStuart J. D. NeilGuy's Hospital

Discussion

Loading...

Member takes

Implication

Highlights tetherin as potential antiviral target; leaves open clinical translation and human pathogenicity effects.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tortorec et al. (2011) studied this question.

synapsesocial.com/papers/6a6ffc80ac440176ef28a38bhttps://doi.org/10.3390/v3050520
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses1996 · 94 citations
  2. 2Modulation of HIV-1-host interaction: role of the Vpu accessory protein2010 · 131 citations
  3. 3HIV-1 Buds Predominantly at the Plasma Membrane of Primary Human Macrophages2007 · 261 citations
  4. 4Antagonism of Tetherin Restriction of HIV-1 Release by Vpu Involves Binding and Sequestration of the Restriction Factor in a Perinuclear Compartment2010 · 216 citations
  5. 5Virus Cell-to-Cell Transmission2010 · 361 citations